Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00258245
What this trial is testing

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT00437034
What this trial is testing

Aflibercept for Relapsed Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)UnknownNCT06126237
What this trial is testing

CM313 in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Keymed Biosciences Co.Ltd 120
Testing effectiveness (Phase 2)UnknownNCT03975907
What this trial is testing

Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)

Who this might be right for
Multiple Myeloma
CARsgen Therapeutics Co., Ltd. 121
Not applicableEnded earlyNCT07045727
What this trial is testing

Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 12
Not applicableEnded earlyNCT06068400
What this trial is testing

Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Guangzhou Bio-gene Technology Co., Ltd 1
Testing effectiveness (Phase 2)Study completedNCT04696809
What this trial is testing

Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Hematologic Malignancies
Janssen Pharmaceutical K.K. 40
Testing effectiveness (Phase 2)UnknownNCT00389701
What this trial is testing

Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sparrow Regional Cancer Center 30
Large-scale testing (Phase 3)UnknownNCT05236621
What this trial is testing

The Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRecurrent or Refractory
Qilu Pharmaceutical Co., Ltd. 85
Large-scale testing (Phase 3)Study completedNCT00750009
What this trial is testing

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Case Comprehensive Cancer Center 583
Testing effectiveness (Phase 2)UnknownNCT03475628
What this trial is testing

Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hellenic Society of Hematology 57
Early research (Phase 1)UnknownNCT04662099
What this trial is testing

T Cells Expressing a Bispecific CAR Targeting CS1 and BCMA in Relapsed/Refractory Multiple Myeloma

Who this might be right for
CS1+ or BCMA+ Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Study completedNCT02461888
What this trial is testing

Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Multiple Myeloma
University of Leeds 112
Testing effectiveness (Phase 2)Study completedNCT01665794
What this trial is testing

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 25
Early research (Phase 1)Ended earlyNCT00176475
What this trial is testing

Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
University of Medicine and Dentistry of New Jersey 2
Early research (Phase 1)UnknownNCT03716856
What this trial is testing

Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
First Affiliated Hospital of Zhejiang University 11
Testing effectiveness (Phase 2)Study completedNCT01755975
What this trial is testing

Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 49
Testing effectiveness (Phase 2)Ended earlyNCT00499239
What this trial is testing

A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaMultiple Myeloma
Gilead Sciences 32
Early research (Phase 1)UnknownNCT05052970
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM

Who this might be right for
Relapsed or Refractory Multiple Myeloma
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07266441
What this trial is testing

JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 168
Next Page